These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 458246)

  • 1. Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets.
    Lockhart MS; Comp PC; Taylor FB
    J Lab Clin Med; 1979 Aug; 94(2):285-94. PubMed ID: 458246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
    Carroll RC; Radcliffe RD; Taylor FB; Gerrard JM
    J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phenomenologic description of clot lysis in dilute human plasma correlating structure and function of platelets.
    Gilliam JM; Berkus V; Taylor FB
    Am J Pathol; 1979 Jul; 96(1):35-50. PubMed ID: 464023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clot retraction facilitates clot lysis.
    Carroll RC; Gerrard JM; Gilliam JM
    Blood; 1981 Jan; 57(1):44-8. PubMed ID: 7448414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
    Gadbut AP; Schullek JR; Hanel AM; MacAllan DR
    Anal Biochem; 1999 May; 270(1):24-32. PubMed ID: 10328761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin network structure: modification by platelets.
    Dhall TZ; Shah GA; Ferguson IA; Dhall DP
    Thromb Haemost; 1983 Feb; 49(1):42-6. PubMed ID: 6845271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
    Parise P; Morini M; Agnelli G; Ascani A; Nenci GG
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):721-7. PubMed ID: 8292721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased retraction of fibrin clots by endothelial cells of infants of diabetic mothers.
    Nappi C; Cerbone AM; Papa R; Di Minno G; Cortese A; Farace MS; Turco S; Montemagno U; Mancini M
    Biol Res Pregnancy Perinatol; 1985; 6(3):141-2. PubMed ID: 3834950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
    van Giezen JJ; Minkema J; Bouma BN; Jansen JW
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):869-75. PubMed ID: 7511944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of clots prepared from whole blood and plasma.
    Taylor FB; Carroll RC; Gerrard J; Esmon CT; Radcliffe RD
    Fed Proc; 1981 May; 40(7):2092-8. PubMed ID: 7194803
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ; Eisenberg PR; Abendschein DR
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.